Keyword: Pharma

News

Erez Israeli Joins Dr. Reddy’s as New Chief Operating Officer

03.04.2018 - On Apr. 2, 2018, Erez Israeli joined Indian pharmaceutical company Dr. Reddy’s as COO and global head of Generics & PSAI. Israeli, former president & CEO of Enzymotec, succeeded...

Markets & Companies

Major Pharma Packaging Trends in 2018

19.03.2018 - Trade shows are excellent places to learn more about the state of an industry. Last month Pharmapack Europe offered a firsthand look at some of the changes and new trends that are...

News

“Pharma Bro” Ordered to Pay $7.4 Million

09.03.2018 - Martin Shkreli, who gained notoriety in 2015 for jacking up the price of Daraprim (pyrimethamine), a 62-year-old drug used to treat toxoplasmosis, has been ordered by a US federal...

News

Catalent Completes Expansion at Singapore Facility

08.03.2018 - Catalent Pharma Solutions has completed the $4.6 million expansion at its Singapore clinical supply facility, announced in Feb. 2016. The New Jersey, USA-based company said the...

News

EU and US Extend Mutual Recognition

06.03.2018 - The EU and the US Food and Drug Administration (FDA) have extended their agreement on recognizing each other’s medicines inspections to include Greece, Hungary, Czech Republic and...

Markets & Companies

ChemSpec Europe 2018: Online Partnering Program Creates Smart Networking Opportunities

28.02.2018 - ChemSpec Europe 2018: The Fine and Specialty Chemicals exhibition, taking place 20 – 21 June 2018 at Koelnmesse in Cologne, Germany, is known for being a key marketplace for...

Strategy & Management

Lonza Adds More Building Blocks for the Healthcare Continuum

27.02.2018 - Contract development and manufacturing organization (CDMO) Lonza said it exceeded its full-year 2017 guidance. The company reported sales of CHF 5.1 billion. Having closed the...

Markets & Companies

Japan’s Changing Pharmaceutical Landscape

17.01.2018 - Japan has the world’s third largest pharma industry. Yet, for many international companies the market has not proved easy to access. Very high barriers to entry have combined with...